S0202 Gemcitabine and Capecitabine for Unresectable Locally Advanced Metastatic Gallbladder Cancer or Cholangiocarcinoma
Status:
Completed
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as gemcitabine and capecitabine, use different
ways to stop tumor cells from dividing so they stop growing or die. Combining more than one
drug may kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of combining gemcitabine with capecitabine
in treating patients who have locally advanced or metastatic gallbladder cancer or
cholangiocarcinoma.